Global Healthcare Startups Invited to Apply for 12-Week Program with Mentorship, Investor Exposure, and Pitch Competition New York, Sept. 18, 2025 — Cure, a premier healthcare innovation ecosystem headquartered in New York City, today announced the launch of the Cure by Deerfield Middle East Health Accelerator, which is now accepting applications for its first cohort of healthcare startup founders interested in expanding to Qatar, the Middle East and North Africa (MENA) region, and beyond. “At Cure, our mission is to accelerate healthcare innovation by empowering entrepreneurs to take innovative ideas from concept to cure globally,” said Seema Kumar, CEO of Cure. “The Cure by Deerfield Middle East Health Accelerator is an extension of that vision—equipping founders with the education, networks, mentorship, and investor visibility needed to transform promising ideas into real-world health solutions, commercialize faster and at greater scale for patients in Qatar, across MENA, and around the globe.” The accelerator will offer a 12-week hybrid learning program for up to 15 startup teams with expert-led sessions in Doha and New York City, as well as online resources. The program will kick off in New York City at Cure’s The X Factor: Healthcare Innovation Summit (November 11-13, 2025) and cover topics including business models, market dynamics, valuations, negotiations, pitching, fundraising, team building, operational planning, marketing, scaling, and more. The program will culminate in a pitch competition in early 2026 in Doha, where entrepreneurs will present to international investors, connect with leading experts and partners, and compete for the potential opportunity to pilot a new technology in Qatar. The Cure by Deerfield Middle East Health Accelerator is rooted in a collaboration between Cure affiliate Deerfield Management Company and Qatar Investment Authority (QIA) via its Fund of Funds program. The collaboration unites Deerfield's mission of advancing...